Our data suggest that HDL attenuates Ang II–AT1R–EGFR signaling and inhibits VSMC proliferation, supporting the therapeutic potential of HDL in mitigating vascular remodeling and lowering blood pressure in hypertension (Figure 7). This evidence concerns the gene AGTR1 and hypertensive disorder.